Results
3051
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3051 companies
Australis Capital
Market Cap: US$25.4k
Operates as a cannabis company.
AUSA.F
US$0.0001
7D
0%
1Y
0%
Baseline Productions
Market Cap: US$4.1k
Does not have significant operations.
BSSP
US$0.000001
7D
0%
1Y
0%
U.S. Stem Cell
Market Cap: US$66.2k
A biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States.
USRM
US$0.0001
7D
9,900.0%
1Y
n/a
Amarantus BioScience Holdings
Market Cap: US$630.0
A biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine.
AMBS
US$0.000001
7D
0%
1Y
n/a
CEN Biotech
Market Cap: US$65.0
Focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products.
CENB.F
US$0.000001
7D
0%
1Y
0%
co.don
Market Cap: €360.8k
Does not have significant operations.
CNW
€0.013
7D
35.0%
1Y
42.1%
NDT Pharmaceuticals
Market Cap: US$44.8k
A biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury.
NDTP
US$0.094
7D
54.1%
1Y
-66.2%
Isodiol International
Market Cap: US$128.0
Engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States.
ISOL.F
US$0.000001
7D
0%
1Y
0%
Pharmsynthez
Market Cap: ₽1.4b
Public Joint-Stock Company ‘Pharmsynthez’, a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries.
LIFE
₽4.51
7D
0%
1Y
-23.5%
IMGTLtd
Market Cap: ₩57.4b
Engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.
A456570
₩11,200.00
7D
-1.1%
1Y
-12.5%
Hainan Shuangcheng Pharmaceuticals
Market Cap: CN¥3.2b
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
002693
CN¥7.78
7D
-5.1%
1Y
49.0%
HEM Pharma
Market Cap: ₩135.8b
Operates as a microbiome healthcare company in South Korea and internationally.
A376270
₩19,210.00
7D
2.4%
1Y
n/a
Anti-Microbial Savior BioteQ
Market Cap: NT$2.8b
Focuses on the research and development of pharmaceutical products in Taiwan.
6864
NT$87.70
7D
3.2%
1Y
197.8%
Libra Infusions
Market Cap: ৳1.8b
Manufactures and sells injectable intravenous fluids in Bangladesh.
LIBRAINFU
৳815.00
7D
4.7%
1Y
15.9%
Africure Pharmaceuticals
Market Cap: US$57.1m
Manufactures and distributes pharmaceutical products.
AFRP.N0000
US$6.06
7D
0%
1Y
0%
Maven Brands
Market Cap: CA$702.8k
Together with its subsidiary, engages in the production, toll-processing, and packaging of medical cannabis in Canada.
MJ
CA$0.02
7D
0%
1Y
33.3%
Andros PharmaceuticalsLtd
Market Cap: NT$807.6m
A biopharmaceutical company, engages in developing novel drug delivery platform technologies.
6917
NT$17.80
7D
0.8%
1Y
-3.0%
Bharat Immunologicals & Biologicals
Market Cap: ₹930.1m
A biotechnology company, engages in the manufacture and sale of pharmaceutical products in India.
524663
₹21.54
7D
-4.8%
1Y
-27.0%
Proteina
Market Cap: ₩188.7b
Proteina Co.,Ltd. develops protein-protein interaction profiling technology.
A468530
₩17,500.00
7D
4.2%
1Y
n/a
CKD Bio
Market Cap: ₩125.6b
Engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally.
A063160
₩22,900.00
7D
1.8%
1Y
-34.5%
Aoxing Pharmaceutical Company
Market Cap: US$4.1m
A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.
AOXG
US$0.011
7D
64.6%
1Y
72.6%
Yoda Pharmaceuticals
Market Cap: NT$4.0b
An AI-driven company, focuses on advancing drug research and development targeting central nervous system disorders.
7829
NT$50.20
7D
32.1%
1Y
n/a
Hwail PharmaceuticalLtd
Market Cap: ₩93.6b
Develops pharmaceutical raw materials in South Korea.
A061250
₩1,101.00
7D
-1.2%
1Y
-34.1%
Wakamoto PharmaceuticalLtd
Market Cap: JP¥10.7b
Manufactures and sells ethical and non-prescription drugs in Japan.
4512
JP¥308.00
7D
0%
1Y
23.2%
Protect Animal Health
Market Cap: NT$4.3b
Engages in the development of therapeutic vaccines for the animals.
7850
NT$43.65
7D
-1.6%
1Y
n/a
GeneMatrix
Market Cap: ₩48.9b
Develops diagnostic products for various diseases in the field of molecular diagnostics.
A109820
₩2,400.00
7D
-2.4%
1Y
-33.1%
Moogene Medi
Market Cap: ₩22.3b
Develops gene therapies based on its proprietary gene-editing platform technology.
A322970
₩2,215.00
7D
-1.3%
1Y
34.7%
BGM Group
Market Cap: US$1.4b
Through its subsidiaries, operates as a pharmaceutical and chemical company in China.
BGM
US$7.51
7D
-6.4%
1Y
n/a
Curachem
Market Cap: ₩12.3b
Provides services in custom carbon-14 radio labeling, stable isotope labeling, and medical chemistry and process development.
A456190
₩7,000.00
7D
0%
1Y
-58.3%
Dannex Ayrton Starwin
Market Cap: GH₵0
Manufactures and sells pharmaceutical products in Ghana.
DASPHARMA
GH₵0.38
7D
0%
1Y
0%
THC Biomed Intl
Market Cap: CA$3.3m
Produces and sells medical and recreational cannabis in Canada.
THC
CA$0.02
7D
0%
1Y
-50.0%
Pharmicell
Market Cap: ₩668.4b
A biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally.
A005690
₩11,140.00
7D
2.8%
1Y
90.4%
Epibiotech
Market Cap: ₩32.3b
A biopharmaceutical research company, develops cell and antibody treatments for hair restoration medical needs.
A446440
₩14,000.00
7D
4.6%
1Y
37.5%
ORIENT BIO
Market Cap: ₩70.1b
Operates in the bio-industry in South Korea.
A002630
₩591.00
7D
-7.9%
1Y
22.1%
K PharmaInc
Market Cap: JP¥7.8b
Engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan.
4896
JP¥671.00
7D
-3.5%
1Y
-13.5%
Anya Biopharm
Market Cap: NT$3.3b
A pharmaceutical company, develops platform for oral peptides.
7776
NT$67.40
7D
12.3%
1Y
n/a